Generalized Myasthenia Gravis

23 total trials 18 recruiting

Filter these 23 trials by phase, country, sponsor and more.

Open in Search →

Comparative Efficacy of Nipocalimab and Efgartigimod in Myasthenia Gravis Study ID: 80202135MYG3002 EPIC Pending

2025-521130-28-00 5
A Double-Blind, Randomized, Placebo-Controlled Study to Investigate the Safety and Efficacy of Aritinercept, a Dual BAFF/APRIL Inhibitor, in … Pending

2025-525127-27-00 9
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis Recruiting

2025-523950-15-01 4 2026-05-29
An Open-label Study to evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Inebilizumab in children with gMG Recruiting

2025-520993-20-00 4 2026-05-19
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis Recruiting

2024-512126-29-00 5 2025-02-25
Efficacy and Safety of a New Formulation of Oral Cladribine Compared with Placebo in Participants with Generalized Myasthenia Gravis (MyCla … Recruiting

2023-507746-83-00 5 2024-11-27
A Phase 2 study of DNTH103 in patients with Generalized Myasthenia Gravis Recruiting

2024-512865-15-00 4 2024-09-03
Evaluating Long-term Safety of Efgartigimod Administered Intravenously and Subcutaneously in Children With Generalized Myasthenia Gravis (AD … Recruiting

2023-507379-23-00 10 2022-08-18
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis Recruiting

2024-515979-35-00 5 2025-11-13
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Descartes-08 in Patients With Generalized Myasthenia Gravis (MG) Recruiting

2024-520355-25-00 5 2025-10-10
A study to learn how safe zilucoplan is in children with generalized myasthenia gravis who participated in a previous study about zilucoplan Recruiting

2022-502073-42-00 5 2025-08-18
A study to learn how zilucoplan moves throughout the body over time and how safe it is in children with generalized myasthenia gravis Recruiting

2022-502072-23-00 10 2025-07-11
A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety, and tolerability of remibrutinib in patient … Recruiting

2023-510026-32-00 5 2025-06-11
An extension study to find out if multiple treatment cycles of rozanolixizumab are safe and work in children with myasthenia gravis Recruiting

2022-502075-34-00 5 2024-10-08
A randomized, double-blind, placebo-controlled phase III study to evaluate the efficacy, safety, and tolerability of iptacopan in patients w … Recruiting

2023-507064-39-00 5 2024-09-26
A study of efgartigimod PH20 SC in children between 2 and less than 18 years of age with generalized myasthenia gravis Recruiting

2023-506159-12-00 10 2024-09-06
A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Subjects With Generalized Myasthenia Gravis Recruiting

2023-509892-17-00 10 2024-07-09
A study to learn if rozanolixizumab is safe, how it moves through the body, and if it works in children with myasthenia gravis Recruiting

2022-502074-16-00 10 2024-06-14
Efficacy and Safety Study of Nipocalimab IV Infusions for Adults With Generalized Myasthenia Gravis Recruiting

2023-504152-97-00 5 2021-11-26
Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasth … Recruiting

2024-513854-31-00 10 2021-10-27
Single-cell deep phenotyping of B lymphocytes to personalize immunotherapy in patients with Myasthenia Gravis: clinical trial to evaluate th … Recruitment ended

2024-518939-12-00 5 2022-02-28
An extension study to learn if Zilucoplan is safe and works over a long period in adult participants with generalized myasthenia gravis. Recruitment ended

2024-512399-37-00 5 2020-12-29
A study to learn if a Zilucoplan auto-injector is safe and works in adults with myasthenia gravis Ended

2023-508287-30-00 5 2024-08-29

Showing 1–23 of 23 trials